Doxofylline is an antiasthmatic and COPD drug that works as both an adrenergic bronchodilator and phosphodiesterase inhibitor. It is administered 200 mg by NGT twice daily and works by increasing cyclic-3',5'-adenosine monophosphate levels to produce bronchodilation. It is indicated for bronchial asthma but is contraindicated in patients with acute MI, hypotension, lactation, or those allergic to it. Common adverse effects include tachycardia, palpitations, headache, and hyperglycemia. Nursing responsibilities are to monitor lung sounds, vital signs, and sputum before and during administration and observe for paradoxical bronchospasm
Download as DOCX, PDF, TXT or read online on Scribd
0 ratings0% found this document useful (0 votes)
390 views
Doxofylline
Doxofylline is an antiasthmatic and COPD drug that works as both an adrenergic bronchodilator and phosphodiesterase inhibitor. It is administered 200 mg by NGT twice daily and works by increasing cyclic-3',5'-adenosine monophosphate levels to produce bronchodilation. It is indicated for bronchial asthma but is contraindicated in patients with acute MI, hypotension, lactation, or those allergic to it. Common adverse effects include tachycardia, palpitations, headache, and hyperglycemia. Nursing responsibilities are to monitor lung sounds, vital signs, and sputum before and during administration and observe for paradoxical bronchospasm
OF DRUG ROUTE, DURATION OF ADMINISTRATION Adrenergic Cardiac Generic Name: 200 mg NGT BID bronchodilators and Bronchial Contraindicated for disorders: Assess lung Doxofylline phosphodiesterase asthma patients with Acute Tachycardia, sounds, pulse inhibitors both MI, hypotension, and palpitation, and blood Brand Names: work by increasing lactating patients extrasystole. pressure before Ansimar intracellular level of Metabolism and administration cyclic-3’,5’- adenosine nutrition an during peak Classification: monophosphate(cAMP); disorder: of medication. Antiasthmatic & adrenergics by Hyperglycemia. Not amount, COPD increasing production Gastrointestinal color, and preparations and phosphodiesterase disorders: character of - inhibitors by decreasing Nausea, sputum breakdown. Increased vomiting, produced. levels of cAMP produce abdominal pain, bronchodilation. epigastric pain. Monitor Corticosteroids act by General pulmonary decreasing airway disorders and function tests inflammation. administrations: before Irritability. initiating Nervous system therapy and disorders: periodically Headache, during therapy nervousness, to determine dizziness. effectiveness of Psychiatric medication. disorders: Observe for Insomia, paradoxical nervousness. bronchospasm Renal and (wheezing). If urinary conditions disorders: occur, with Albuminuria hold medication and notify physician of other health care professional immediately
Gentamicin _ a Drug Study Presented to the Faculty of the Nursing Department Mrs. Mylahrose Jovita N. Acaba, RN, MN _ in Partial Fulfillment of the Requirements in NCM 209-RLE INTEGRATED MANAGEMENT of CHILDHOON (1)